Penbrook Management LLC Buys Cerence Inc, Intevac Inc, XPEL Inc, Sells Chegg Inc, Hewlett Packard Enterprise Co, SPDR S&P 500

Author's Avatar
[email protected]
Apr 14, 2020
Article's Main Image
New York, NY, based Investment company Penbrook Management LLC (Current Portfolio) buys Cerence Inc, Intevac Inc, XPEL Inc, Hess Midstream Operations LP, BioLife Solutions Inc, sells Chegg Inc, Hewlett Packard Enterprise Co, SPDR S&P 500, Hess Midstream Operations LP, ConocoPhillips during the 3-months ended 2020Q1, according to the most recent filings of the investment company, Penbrook Management LLC. As of 2020Q1, Penbrook Management LLC owns 101 stocks with a total value of $78 million. These are the details of the buys and sells.

For the details of Penbrook Management LLC's stock buys and sells, go to https://www.gurufocus.com/guru/penbrook+management+llc/current-portfolio/portfolio

These are the top 5 holdings of Penbrook Management LLC
  1. Novo Nordisk A/S (NVO) - 126,350 shares, 9.78% of the total portfolio. Shares reduced by 0.39%
  2. Microsoft Corp (MSFT) - 41,806 shares, 8.48% of the total portfolio. Shares reduced by 1.12%
  3. Amazon.com Inc (AMZN) - 2,550 shares, 6.39% of the total portfolio. Shares reduced by 3.77%
  4. Moody's Corporation (MCO) - 13,500 shares, 3.67% of the total portfolio. Shares reduced by 3.23%
  5. Thomson Reuters Corp (TRI) - 30,784 shares, 2.69% of the total portfolio. Shares reduced by 0.58%
New Purchase: Cerence Inc (CRNC)

Penbrook Management LLC initiated holding in Cerence Inc. The purchase prices were between $13.45 and $26.65, with an estimated average price of $21.1. The stock is now traded at around $21.11. The impact to a portfolio due to this purchase was 1.73%. The holding were 87,406 shares as of .

New Purchase: Intevac Inc (IVAC)

Penbrook Management LLC initiated holding in Intevac Inc. The purchase prices were between $3.38 and $7.56, with an estimated average price of $6.04. The stock is now traded at around $4.89. The impact to a portfolio due to this purchase was 0.61%. The holding were 116,120 shares as of .

New Purchase: XPEL Inc (XPX)

Penbrook Management LLC initiated holding in XPEL Inc. The purchase prices were between $7.85 and $16, with an estimated average price of $12.3. The stock is now traded at around $10.90. The impact to a portfolio due to this purchase was 0.49%. The holding were 38,140 shares as of .

New Purchase: Hess Midstream Operations LP (HESM)

Penbrook Management LLC initiated holding in Hess Midstream Operations LP. The purchase prices were between $6.24 and $25.58, with an estimated average price of $19.02. The stock is now traded at around $13.72. The impact to a portfolio due to this purchase was 0.33%. The holding were 25,230 shares as of .

New Purchase: Maverix Metals Inc (MMX)

Penbrook Management LLC initiated holding in Maverix Metals Inc. The purchase prices were between $2.83 and $5.46, with an estimated average price of $4.5. The stock is now traded at around $4.20. The impact to a portfolio due to this purchase was 0.04%. The holding were 10,000 shares as of .

Added: BioLife Solutions Inc (BLFS)

Penbrook Management LLC added to a holding in BioLife Solutions Inc by 69.44%. The purchase prices were between $8.36 and $17.03, with an estimated average price of $13.83. The stock is now traded at around $10.42. The impact to a portfolio due to this purchase was 0.23%. The holding were 45,995 shares as of .

Added: Chembio Diagnostics Inc (CEMI)

Penbrook Management LLC added to a holding in Chembio Diagnostics Inc by 20.73%. The purchase prices were between $2.36 and $5.6, with an estimated average price of $4.05. The stock is now traded at around $9.42. The impact to a portfolio due to this purchase was 0.22%. The holding were 197,560 shares as of .

Added: Invesco Municipal Trust (VKQ)

Penbrook Management LLC added to a holding in Invesco Municipal Trust by 50.00%. The purchase prices were between $9.63 and $13.03, with an estimated average price of $12.38. The stock is now traded at around $11.84. The impact to a portfolio due to this purchase was 0.15%. The holding were 30,000 shares as of .

Added: OncoCyte Corp (OCX)

Penbrook Management LLC added to a holding in OncoCyte Corp by 21.91%. The purchase prices were between $1.76 and $3.02, with an estimated average price of $2.46. The stock is now traded at around $2.32. The impact to a portfolio due to this purchase was 0.12%. The holding were 215,625 shares as of .

Sold Out: Hewlett Packard Enterprise Co (HPE)

Penbrook Management LLC sold out a holding in Hewlett Packard Enterprise Co. The sale prices were between $7.83 and $16.17, with an estimated average price of $13.19.

Sold Out: Hess Midstream Operations LP (5HM)

Penbrook Management LLC sold out a holding in Hess Midstream Operations LP. The sale prices were between $5.66 and $22.57, with an estimated average price of $17.02.

Sold Out: ConocoPhillips (COP)

Penbrook Management LLC sold out a holding in ConocoPhillips. The sale prices were between $22.67 and $66.48, with an estimated average price of $51.43.

Sold Out: Core Laboratories NV (CLB)

Penbrook Management LLC sold out a holding in Core Laboratories NV. The sale prices were between $7.99 and $41.24, with an estimated average price of $28.39.

Sold Out: International Business Machines Corp (IBM)

Penbrook Management LLC sold out a holding in International Business Machines Corp. The sale prices were between $94.77 and $156.76, with an estimated average price of $132.68.

Sold Out: Chevron Corp (CVX)

Penbrook Management LLC sold out a holding in Chevron Corp. The sale prices were between $54.22 and $121.43, with an estimated average price of $99.58.



Here is the complete portfolio of Penbrook Management LLC. Also check out:

1. Penbrook Management LLC's Undervalued Stocks
2. Penbrook Management LLC's Top Growth Companies, and
3. Penbrook Management LLC's High Yield stocks
4. Stocks that Penbrook Management LLC keeps buying
Rating:
0 / 5 (0 votes)